Literature DB >> 20632

Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding.

C Braestrup, R F Squires.   

Abstract

[3H]Diazepam appears to bind specifically to a single, saturable, binding site located on rat brain membranes, with an affinity constant near 3 nM at pH 7.4. Specific binding constitutes more than 90% of total binding at 0 degrees and less than 10% of total binding at 37 degrees. Arrhenius plots suggest a sharp conformational change in the diazepam receptor near 18 degrees. Mitochondrial fractions from rat kidney, liver, and lung exhibit some [3H]diazepam binding that can be displaced by nonradioactive diazepam and several other benzodiazepines. However, Ro-4864, which is almost inactive in displacing [3H]diazepam from brain membranes, is extremely potent in displacing it from kidney mitochondria. Conversely, clonazepam, the most potent inhibitor of brain binding, is an extremely weak inhibitor of kidney binding. Furthermore, diazepam binding to kidney mitochondria has an affinity constantof 40 nM, about 15 times higher than that in brain. No specific diazepam binding was detected in intestine or skeletal muscle. Thus, specific [3H]diazepam binding to membranes appears to be restricted to brain, where it is unevenly distributed: the density of diazepam receptors is about five times higher in cortex (the highest density) than in pons-meddula (lowest density). Trypsin and chymotrypsin completely abolished specific [3H]diazepambinding in brain and kidney.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 20632      PMCID: PMC431738          DOI: 10.1073/pnas.74.9.3805

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  Regional and subcellular distributions of brain neurotensin.

Authors:  G R Uhl; S H Snyder
Journal:  Life Sci       Date:  1976-12-15       Impact factor: 5.037

2.  An endogenous morphine-like factor in mammalian brain.

Authors:  G W Pasternak; R Goodman; S H Snyder
Journal:  Life Sci       Date:  1975-06-15       Impact factor: 5.037

3.  Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine.

Authors:  J Hughes
Journal:  Brain Res       Date:  1975-05-02       Impact factor: 3.252

Review 4.  New concepts on the mechanism of action of benzodiazepines.

Authors:  E Costa; A Guidotti; C C Mao; A Suria
Journal:  Life Sci       Date:  1975-07-15       Impact factor: 5.037

Review 5.  Possible involvement of GABA in the central actions of benzodiazepines.

Authors:  W Haefely; A Kulcsár; H Möhler; L Pieri; P Polc; R Schaffner
Journal:  Adv Biochem Psychopharmacol       Date:  1975

6.  Characterization of the binding of benzodiazepines to human serum albumin.

Authors:  W Müller; U Wollert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

7.  Radioimmunoassay for substance P.

Authors:  D Powell; S Leeman; G W Tregear; H D Niall; J T Potts
Journal:  Nat New Biol       Date:  1973-02-21

8.  Opiate receptor: demonstration in nervous tissue.

Authors:  C B Pert; S H Snyder
Journal:  Science       Date:  1973-03-09       Impact factor: 47.728

9.  Additional evidence for the existence of several forms of mitochondrial monoamine oxidase in the mouse.

Authors:  R F Squires
Journal:  Biochem Pharmacol       Date:  1968-07       Impact factor: 5.858

10.  Interaction of benzodiazepines with central nervous glycine receptors: possible mechanism of action.

Authors:  A B Young; S R Zukin; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205

View more
  216 in total

Review 1.  The peripheral benzodiazepine receptors: a review.

Authors:  A Beurdeley-Thomas; L Miccoli; S Oudard; B Dutrillaux; M F Poupon
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

2.  Benzodiazepine receptors in the brain as affected by different experimental stresses: the changes are small and not undirectional.

Authors:  C Braestrup; M Nielsen; E B Nielsen; M Lyon
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

Review 3.  GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam.

Authors:  Raman Sankar
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

4.  Increased GABAA-dependent chloride uptake in mice selectively bred for low aggressive behavior.

Authors:  E M Weerts; L G Miller; K E Hood; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Localization of the peripheral-type benzodiazepine binding site to mitochondria of human glioma cells.

Authors:  J M Olson; W McNeel; A B Young; W R Mancini
Journal:  J Neurooncol       Date:  1992-05       Impact factor: 4.130

Review 6.  Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states.

Authors:  Amani Batarseh; Vassilios Papadopoulos
Journal:  Mol Cell Endocrinol       Date:  2010-06-30       Impact factor: 4.102

7.  Subregion-Specific Impacts of Genetic Loss of Diazepam Binding Inhibitor on Synaptic Inhibition in the Murine Hippocampus.

Authors:  Connor D Courtney; Catherine A Christian
Journal:  Neuroscience       Date:  2018-07-19       Impact factor: 3.590

8.  A comparison between chlordiazepoxide and CL 218,872, a synthetic non-benzodiazepine ligand for benzodiazepine receptors, on serotonin and catecholamine turnover in brain.

Authors:  J F McElroy; R S Feldman; J S Meyer
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 9.  Classics in chemical neuroscience: diazepam (valium).

Authors:  Nicholas E Calcaterra; James C Barrow
Journal:  ACS Chem Neurosci       Date:  2014-02-27       Impact factor: 4.418

10.  Benzodiazepine receptors mediate regional blood flow changes in the living human brain.

Authors:  E Matthew; P Andreason; K Pettigrew; R E Carson; P Herscovitch; R Cohen; C King; C E Johanson; D J Greenblatt; S M Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.